GATA 2 Deficiency: Focus on Immune System Impairment.

GATA2 deficiency autoimmune disease hematopoietic stem cell transplantation inborn errors of immunity myelodysplastic syndromes recurrent infection transcription factors

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 30 01 2022
accepted: 19 05 2022
entrez: 30 6 2022
pubmed: 1 7 2022
medline: 2 7 2022
Statut: epublish

Résumé

GATA2 deficiency is a disease with a broad spectrum of clinical presentation, ranging from lymphedema, deafness, pulmonary dysfunction to miscarriage and urogenital anomalies, but it is mainly recognized as an immune system and bone marrow disorder. It is caused by various heterozygous mutations in the

Identifiants

pubmed: 35769478
doi: 10.3389/fimmu.2022.865773
pmc: PMC9234111
doi:

Substances chimiques

GATA2 Transcription Factor 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

865773

Informations de copyright

Copyright © 2022 Fabozzi, Mastronuzzi, Ceglie, Masetti and Leardini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancers (Basel). 2021 Mar 26;13(7):
pubmed: 33810369
Blood. 2020 Aug 20;136(8):1002-1005
pubmed: 32556109
Nature. 1994 Sep 15;371(6494):221-6
pubmed: 8078582
Blood Adv. 2020 Sep 22;4(18):4584-4592
pubmed: 32960960
Br J Haematol. 2022 Jan;196(1):169-178
pubmed: 34580862
IUBMB Life. 2020 Jan;72(1):151-158
pubmed: 31785092
Hum Mutat. 2021 Nov;42(11):1399-1421
pubmed: 34387894
Blood. 2017 Apr 13;129(15):2103-2110
pubmed: 28179280
Cancers (Basel). 2020 Oct 13;12(10):
pubmed: 33066218
Lancet Infect Dis. 2015 Aug;15(8):968-80
pubmed: 26049967
Semin Hematol. 2017 Apr;54(2):81-86
pubmed: 28637621
J Allergy Clin Immunol. 2012 Nov;130(5):1030-48
pubmed: 23036745
J Exp Med. 2011 Feb 14;208(2):227-34
pubmed: 21242295
Blood. 2014 Feb 6;123(6):809-21
pubmed: 24227816
Blood. 2011 Sep 8;118(10):2653-5
pubmed: 21670465
J Leukoc Biol. 2016 Jun;99(6):1065-76
pubmed: 26710799
Haematologica. 2014 Feb;99(2):276-81
pubmed: 24077845
Hematol Oncol Clin North Am. 2018 Aug;32(4):713-728
pubmed: 30047422
Cancer Sci. 2019 Apr;110(4):1183-1193
pubmed: 30710465
Nat Genet. 2011 Sep 04;43(10):1012-7
pubmed: 21892162
Sci Rep. 2020 May 20;10(1):8305
pubmed: 32433473
Age (Dordr). 2013 Jun;35(3):985-91
pubmed: 22415616
N Engl J Med. 2021 Jan 21;384(3):252-260
pubmed: 33283989
Dev Dyn. 2010 Sep;239(9):2452-69
pubmed: 20652952
Nat Genet. 2011 Sep 04;43(10):929-31
pubmed: 21892158
Leukemia. 2020 Oct;34(10):2673-2687
pubmed: 32555368
N Engl J Med. 1989 Jun 29;320(26):1731-5
pubmed: 2543925
Bone Marrow Transplant. 2021 Nov;56(11):2732-2741
pubmed: 34244664
Blood. 2011 Sep 8;118(10):2656-8
pubmed: 21765025
Br J Haematol. 2015 Apr;169(2):173-87
pubmed: 25707267
Blood. 2016 Mar 17;127(11):1387-97; quiz 1518
pubmed: 26702063
J Clin Invest. 2012 Oct;122(10):3692-704
pubmed: 22996659
Chest. 2021 Oct;160(4):1350-1359
pubmed: 34089740
Commun Biol. 2022 Apr 19;5(1):376
pubmed: 35440757
Blood Adv. 2021 Dec 28;5(24):5631-5635
pubmed: 34638133
Best Pract Res Clin Haematol. 2021 Jun;34(2):101278
pubmed: 34404529
Front Genome Ed. 2020 Nov 26;2:602182
pubmed: 34713225
Front Immunol. 2017 Dec 22;8:1869
pubmed: 29375553
Blood. 2014 Feb 6;123(6):863-74
pubmed: 24345756
Blood. 2005 Jul 15;106(2):477-84
pubmed: 15811962
Ann Hematol. 2018 Nov;97(11):2015-2023
pubmed: 30091023
IUBMB Life. 2020 Jan;72(1):142-150
pubmed: 31675473
Blood. 2012 Feb 2;119(5):1283-91
pubmed: 22147895
Leukemia. 2018 Nov;32(11):2502-2507
pubmed: 29749400
J Clin Immunol. 2020 Jan;40(1):66-81
pubmed: 32048120
Br J Haematol. 2014 Jan;164(1):142-5
pubmed: 24033149
Blood. 2013 Apr 4;121(14):2669-77
pubmed: 23365458
Nat Med. 2021 Oct;27(10):1806-1817
pubmed: 34621053
Am J Reprod Immunol. 2021 Aug;86(2):e13433
pubmed: 33896061
Leuk Lymphoma. 2019 Apr;60(4):1053-1061
pubmed: 30714451
Genes Cells. 2008 Feb;13(2):159-70
pubmed: 18233958
Curr Opin Allergy Clin Immunol. 2015 Feb;15(1):104-9
pubmed: 25397911
Blood. 2020 Aug 20;136(8):923-924
pubmed: 32818248
Haematologica. 2018 Aug;103(8):1278-1287
pubmed: 29724903
Best Pract Res Clin Haematol. 2020 Sep;33(3):101197
pubmed: 33038986

Auteurs

Francesco Fabozzi (F)

Department of Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, Italy.
Department of Pediatrics, Università degli Studi di Roma Tor Vergata, Rome, Italy.

Angela Mastronuzzi (A)

Department of Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, Italy.

Giulia Ceglie (G)

Department of Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, Italy.
Department of Pediatrics, Università degli Studi di Roma Tor Vergata, Rome, Italy.

Riccardo Masetti (R)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Davide Leardini (D)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH